Product Program year 2025 Source: CMS Open Payments

Altuviiio

Biological Hematology

NDC 71104-981-01

Open in the dashboard

General payments

$3,023,715

3,233 payments

Research payments

$71,700

6 payments

Through program year 2025, $3,023,715 in general payments and $71,700 in research payments were reported against Altuviiio (Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $1,118,205 1,050
2025 Research $51,700 4
2024 General $1,165,132 1,262
2024 Research $20,000 2
2023 General $740,378 921

Breakdown

Who paid General payments · program years 2023–2025
  1. Genzyme Corporation $2,830,058 3,200 payments
  2. Sanofi US Services Inc. $178,035 19 payments
  3. Sanofi-Aventis U.S. LLC $15,622 14 payments
Top recipients General payments · program year 2025
  1. Maissaa Janbain Hematology & Oncology · New Orleans, LA $71,592 6% · 25 payments
  2. Doris Quon Hematology · Los Angeles, CA $64,226 6% · 41 payments
  3. Guy Young Pediatric Hematology-Oncology · Bozeman, MT $56,567 5% · 24 payments
  4. Shveta Gupta Pediatric Hematology-Oncology · Orlando, FL $53,927 5% · 29 payments
  5. Akshat Jain Pediatric Hematology-Oncology · Redlands, CA $50,020 4% · 22 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pediatric Hematology-Oncology Pediatrics $672,126 60% · 99 practitioners
  2. Hematology & Oncology Internal Medicine $228,142 20% · 86 practitioners
  3. Hematology Internal Medicine $64,679 6% · 12 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $49,714 4% · 50 practitioners
  5. Pediatrics $41,599 4% · 20 practitioners

The top 5 of 31 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $316,446 28% · 34 recipients
  2. Florida $124,427 11% · 44 recipients
  3. Louisiana $120,340 11% · 9 recipients
  4. Texas $72,223 6% · 52 recipients
  5. Kentucky $58,695 5% · 2 recipients

The top 5 of 41 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

3,233 general · 6 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record